Cargando…

Validity of the ESC Risk Assessment in Idiopathic Pulmonary Arterial Hypertension in China

Background: The 2015 European pulmonary hypertension (PH) guidelines recommend a risk stratification strategy for pulmonary arterial hypertension (PAH). We aimed to investigate the validation and potential prognostic information in Chinese patients. Methods: The risk assessment variables proposed by...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gong, Su-Gang, Wu, Wen-Hui, Li, Chao, Zhao, Qin-Hua, Jiang, Rong, Luo, Ci-Jun, Qiu, Hong-Ling, Liu, Jin-Ming, Wang, Lan, Zhang, Rui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8645595/ https://www.ncbi.nlm.nih.gov/pubmed/34881304 http://dx.doi.org/10.3389/fcvm.2021.745578

Ejemplares similares

Prognostic Value of Gamma-Glutamyltransferase in Male Patients With Idiopathic Pulmonary Arterial Hypertension
por: Lu, Gang-Hua, et al.
Publicado: (2020)

Echocardiographic Prognosis Relevance of Attenuated Right Heart Remodeling in Idiopathic Pulmonary Arterial Hypertension
por: Zhao, Qin-Hua, et al.
Publicado: (2021)

Differences in disease severity and prognosis of exercise-induced right-to-left shunt between idiopathic pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension patients
por: Wang, Shang, et al.
Publicado: (2022)

Liver dysfunction in idiopathic pulmonary arterial hypertension: prevalence, characteristics and prognostic significance, a retrospective cohort study in China
por: Luo, Cijun, et al.
Publicado: (2021)

Comparative Effectiveness of Exercise Training for Patients With Chronic Thromboembolic Pulmonary Hypertension After Pulmonary Endarterectomy: A Systematic Review and Meta-Analysis
por: Zhao, Ya-Lin, et al.
Publicado: (2021)

Efficacy and safety of switching from bosentan or ambrisentan to macitentan in pulmonary arterial hypertension: A systematic review and meta-analysis
por: Li, Jie, et al.
Publicado: (2022)

Alteration of Extracellular Superoxide Dismutase in Idiopathic Pulmonary Arterial Hypertension
por: Zhang, Rui, et al.
Publicado: (2020)

Sex-specific differences in sleep-disordered breathing and nocturnal hypoxemia in chronic thromboembolic pulmonary hypertension and chronic thromboembolic pulmonary disease
por: Li, Hui-Ting, et al.
Publicado: (2022)

The Role of Glutamine and Glutaminase in Pulmonary Hypertension
por: Wang, Shang, et al.
Publicado: (2022)

Whole Exome Sequencing of Patients With Heritable and Idiopathic Pulmonary Arterial Hypertension in Central Taiwan
por: Liang, Kae-Woei, et al.
Publicado: (2022)

Identification of Potential Biomarkers and Immune Infiltration Characteristics in Idiopathic Pulmonary Arterial Hypertension Using Bioinformatics Analysis
por: Zeng, Haowei, et al.
Publicado: (2021)

Essential Genes and MiRNA–mRNA Network Contributing to the Pathogenesis of Idiopathic Pulmonary Arterial Hypertension
por: Hao, Shengyu, et al.
Publicado: (2021)

Identification of immune-related hub genes and analysis of infiltrated immune cells of idiopathic pulmonary artery hypertension
por: Chen, Yubin, et al.
Publicado: (2023)

An Overview of Circulating Pulmonary Arterial Hypertension Biomarkers
por: Santos-Gomes, Joana, et al.
Publicado: (2022)

Predictors of Maternal Death Among Women With Pulmonary Hypertension in China From 2012 to 2020: A Retrospective Single-Center Study
por: Dai, Ling-Ling, et al.
Publicado: (2022)

Long-term outcomes in health-related quality of life influence chronic disease management in patients with pulmonary hypertension
por: Li, Jin-Ling, et al.
Publicado: (2022)

Management of pregnant patients with pulmonary arterial hypertension
por: Zhang, Xiao, et al.
Publicado: (2022)

Right Ventricle to Pulmonary Artery Coupling Predicts the Risk Stratification in Patients With Systemic Sclerosis-Associated Pulmonary Arterial Hypertension
por: Lai, Jinzhi, et al.
Publicado: (2022)

Donepezil Ameliorates Pulmonary Arterial Hypertension by Inhibiting M2-Macrophage Activation
por: Qiu, Haihua, et al.
Publicado: (2021)

Novel hub genes associated with pulmonary artery remodeling in pulmonary hypertension
por: Tan, Rubin, et al.
Publicado: (2022)

Circulating Interleukin-7 in Human Pulmonary Arterial Hypertension
por: Diekmann, Franziska, et al.
Publicado: (2021)

A giant pulmonary artery aneurysm in a patient with severe idiopathic pulmonary arterial hypertension
por: Sonaglioni, Andrea, et al.
Publicado: (2022)

Echocardiographic Evaluation of Initial Ambrisentan Plus Phosphodiesterase Type 5 Inhibitor on Right Ventricular Pulmonary Artery Coupling in Severe Pulmonary Arterial Hypertension Patients
por: Lan, Wei-Fang, et al.
Publicado: (2022)

Case report: Transected Hickman catheter and its thrombotic occlusion in a patient with idiopathic pulmonary arterial hypertension—can a catheter replacement be avoided?
por: Sławiński, Grzegorz, et al.
Publicado: (2023)

Case report: Beneficial long-term effect of the atrial-flow-regulator device in a pediatric patient with idiopathic pulmonary arterial hypertension and recurring syncope
por: Pattathu, Joseph, et al.
Publicado: (2023)

Time to clinical improvement: an appropriate surrogate endpoint for pulmonary arterial hypertension medication trials
por: Wang, An, et al.
Publicado: (2023)

A Study of the Efficacy and Safety of Aerobic Exercise Training in Pulmonary Arterial Hypertension (the Saturday Study): Protocol for a Prospective, Randomized, and Controlled Trial
por: Jiang, Rong, et al.
Publicado: (2022)

Autoimmunity in Pulmonary Arterial Hypertension: Evidence for Local Immunoglobulin Production
por: Shu, Ting, et al.
Publicado: (2021)

Notopterol Attenuates Monocrotaline-Induced Pulmonary Arterial Hypertension in Rat
por: Huang, Lin, et al.
Publicado: (2022)

Risk Factors of Pulmonary Arterial Hypertension and Its Relationship With Atrial Fibrillation in Patients With Obstructive Hypertrophic Cardiomyopathy
por: Nie, Changrong, et al.
Publicado: (2021)

Sustained Hemodynamic and Clinical Improvements for a Patient With Idiopathic Pulmonary Arterial Hypertension Over 1.5 Years After Balloon Atrial Septostomy: A Case Report
por: Liang, Kae-Woei, et al.
Publicado: (2022)

Sex Differences, Estrogen Metabolism and Signaling in the Development of Pulmonary Arterial Hypertension
por: Sun, Yanan, et al.
Publicado: (2021)

Glutaminolysis: A Driver of Vascular and Cardiac Remodeling in Pulmonary Arterial Hypertension
por: Mprah, Richard, et al.
Publicado: (2021)

Echocardiographic, Biochemical, and Electrocardiographic Correlates Associated With Progressive Pulmonary Arterial Hypertension
por: Zaky, Ahmed, et al.
Publicado: (2021)

Schistosome-Associated Pulmonary Arterial Hypertension: A Review Emphasizing Pathogenesis
por: Ferrari, Teresa Cristina Abreu, et al.
Publicado: (2021)

Relaxin Inhibits Ventricular Arrhythmia and Asystole in Rats With Pulmonary Arterial Hypertension
por: Martin, Brian, et al.
Publicado: (2021)

Construction of a diagnostic signature and immune landscape of pulmonary arterial hypertension
por: Duo, Mengjie, et al.
Publicado: (2022)

Pulmonary arterial hypertension associated with congenital heart disease: An omics study
por: Zhao, Maolin, et al.
Publicado: (2023)

Metabolic Reprogramming in the Heart and Lung in a Murine Model of Pulmonary Arterial Hypertension
por: Izquierdo-Garcia, Jose L., et al.
Publicado: (2018)

Clinical Relevance of Right Atrial Functional Response to Treatment in Pulmonary Arterial Hypertension
por: Richter, Manuel J., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qiu9f33o1nto7hg6stds5ibv54